We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2021, it operated 23 cancer centers, including 1 center of excellence in Bengaluru, 2 freestanding diagnostic centers, and 1 day care chemotherapy center across India, as well as 1 cancer center in Africa. The company was founded in 1989 and is based in Bengaluru, India.
TODAY'S HIGH
287.05
TODAY'S LOW
281.35
52 WEEK HIGH
308.8
52 WEEK LOW
212.5
% of Shares Held by
All Insider
73.86%
% of Shares Held by
Institutions
8.25%
% of Float Held by
Institutions
31.56%
Number of Institutions
Holding Shares
9
MARKET CAP
3945.27 Cr.
ETERPRISE VALUE
4618.64 Cr.
NO. OF SHARES
13.90 Cr.
BOOK VALUE
62.475
DIV. YIELD
None%
DEBT
914.66 Cr.
GROSS PROFIT
513.42 Cr.
CASH
231.64 Cr.
REVENUE
1482.69 Cr.
REVENUE/SHARE
111.752
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 155.41 Cr. | -288.36 Cr. | 3.50 Cr. | -5.68 Cr. |
| Change To Liabilities | 44.30 Cr. | 52.89 Cr. | 18.18 Cr. | 46.17 Cr. |
| Total cashflows from Investing Activities | 124.58 Cr. | -171.10 Cr. | -101.38 Cr. | -238.19 Cr. |
| Net Borrowings | -191.36 Cr. | -205.98 Cr. | 23.12 Cr. | 129.53 Cr. |
| Total Cash from Financing Activities | -154.88 Cr. | 112.24 Cr. | -58.42 Cr. | 83.51 Cr. |
| Other Liabilities | -8.30 Cr. | 7.87 Cr. | -11.76 Cr. | -8.56 Cr. |
| Total Assets | 132.16 Cr. | 452.61 Cr. | 20.32 Cr. | 9.30 Lakhs |
| Net Income | 53.73 Cr. | -193.46 Cr. | -106.69 Cr. | -24.79 Cr. |
| Change in Cash | 189.82 Cr. | 61.65 Cr. | -29.67 Cr. | -56.18 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 220.12 Cr. | 120.52 Cr. | 130.13 Cr. | 98.50 Cr. |
| Depreciation | 158.28 Cr. | 147.18 Cr. | 142.31 Cr. | 81.84 Cr. |
| Other Cashflows from Investing Activities | 157.04 Cr. | 159.02 Cr. | 2.50 Cr. | -11.66 Cr. |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Change to Inventory | -6.08 Cr. | 2.15 Cr. | 3.51 Cr. | -2.74 Cr. |
| Change to Account Receivables | -40.44 Cr. | -7.84 Cr. | -32.58 Cr. | -32.75 Cr. |
| Other Cashflows from Financing Activities | -95.68 Cr. | -134.39 Cr. | -101.87 Cr. | -46.11 Cr. |
| Change to Net Income | 18.63 Cr. | 99.69 Cr. | 111.03 Cr. | 36.11 Cr. |
| Capital Expenditures | -71.23 Cr. | -35.42 Cr. | -107.81 Cr. | -188.78 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 87.77 Cr. | -228.66 Cr. | -119.26 Cr. | -33.37 Cr. |
| Minority Interest | 13.43 Cr. | 16.82 Cr. | 38.51 Cr. | 45.54 Cr. |
| Net Income | 79.70 Cr. | -33.37 Cr. | 22.94 Cr. | 39.60 Cr. |
| Selling General Administrative | 0 | 18.95 Cr. | 26.37 Cr. | 68.51 Cr. |
| Gross Profit | 513.42 Cr. | 527.39 Cr. | 612.05 Cr. | 574.93 Cr. |
| Ebit | 79.70 Cr. | -33.37 Cr. | 22.94 Cr. | 39.60 Cr. |
| Operating Income | 79.70 Cr. | -33.37 Cr. | 22.94 Cr. | 39.60 Cr. |
| Other Operating Expenses | 275.44 Cr. | 382.59 Cr. | 411.74 Cr. | 381.72 Cr. |
| Interest Expense | -97.77 Cr. | -113.66 Cr. | -123.45 Cr. | -50.48 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 48.85 Cr. | -7.56 Cr. | 6.18 Cr. | -2.50 Cr. |
| Total Revenue | 1397.79 Cr. | 1013.43 Cr. | 1095.63 Cr. | 978.67 Cr. |
| Total Operating Expenses | 1318.09 Cr. | 1046.80 Cr. | 1072.69 Cr. | 939.06 Cr. |
| Cost of Revenue | 884.37 Cr. | 486.03 Cr. | 483.58 Cr. | 403.74 Cr. |
| Total Other Income Expense Net | 8.07 Cr. | -195.28 Cr. | -142.21 Cr. | -72.98 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 38.92 Cr. | -221.10 Cr. | -125.45 Cr. | -30.87 Cr. |
| Net Income Applicable to Common Shares | 53.73 Cr. | -193.46 Cr. | -106.69 Cr. | -24.79 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 29.80 Cr. | 21.48 Cr. | 32 Cr. | 9.33 Cr. |
| Capital Surplus | 0 | 997.45 Cr. | 579.62 Cr. | 558.73 Cr. |
| Total Liabilities | 1335.81 Cr. | 1321.61 Cr. | 1833.40 Cr. | 1131.35 Cr. |
| Stock Holder Equity | 870.29 Cr. | 697.17 Cr. | 381.25 Cr. | 476.64 Cr. |
| Minority Interest | 13.43 Cr. | 16.82 Cr. | 38.51 Cr. | 45.54 Cr. |
| Other Liabilities | 172.62 Cr. | 142.65 Cr. | 236.11 Cr. | 275.02 Cr. |
| Total Assets | 2219.53 Cr. | 2035.61 Cr. | 2253.17 Cr. | 1653.54 Cr. |
| Common Stock | 139.01 Cr. | 125.35 Cr. | 88.69 Cr. | 87.91 Cr. |
| Retained Earnings | 0 | -475.10 Cr. | -292.22 Cr. | -173.21 Cr. |
| Other Liabilities | 37.29 Cr. | 40.88 Cr. | 118.87 Cr. | 67.12 Cr. |
| Good Will | 181.27 Cr. | 96.34 Cr. | 109.34 Cr. | 109.34 Cr. |
| Treasury Stock | 731.28 Cr. | 49.46 Cr. | 5.16 Cr. | 3.20 Cr. |
| Other Assets | 139.50 Cr. | 149.95 Cr. | 206.60 Cr. | 189 Cr. |
| Cash | 197.51 Cr. | 30 Cr. | 31.74 Cr. | 20.51 Cr. |
| Current Liabilities | 469.75 Cr. | 465.24 Cr. | 575.74 Cr. | 547.31 Cr. |
| Long Term Asset Charges | 5.95 Cr. | 34.31 Cr. | 26.14 Cr. | 26.86 Cr. |
| Short Long Term Debt | 44.76 Cr. | 32.96 Cr. | 24.03 Cr. | 26.63 Cr. |
| Other Stockholder Equity | 731.28 Cr. | 49.46 Cr. | 5.16 Cr. | 3.20 Cr. |
| Property Plant Equipment | 1357.80 Cr. | 1294.56 Cr. | 1550.82 Cr. | 1004.17 Cr. |
| Total Cur. Assets | 502.35 Cr. | 434.96 Cr. | 303.78 Cr. | 272.96 Cr. |
| Long Term Investments | 8.81 Cr. | 38.30 Cr. | 50.61 Cr. | 68.73 Cr. |
| Net Tangible Assets | 659.22 Cr. | 579.35 Cr. | 239.90 Cr. | 357.97 Cr. |
| Short Term Investments | 34.13 Cr. | 135.73 Cr. | 10.49 Cr. | 6.61 Cr. |
| Net Receivables | 219.06 Cr. | 214.79 Cr. | 208.06 Cr. | 188.74 Cr. |
| Long Term Debt | 362.87 Cr. | 346.17 Cr. | 529.61 Cr. | 460.53 Cr. |
| Inventory | 29.97 Cr. | 21.10 Cr. | 23.25 Cr. | 26.77 Cr. |
| Accounts Payable | 193.95 Cr. | 145.51 Cr. | 153.57 Cr. | 152.74 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account